Back
 JCT  Vol.12 No.10 , October 2021
Erratum to “Response of Subcutaneous Xenografts of Endometrial Cancer in Nude Mice to Inhibitors of Phosphatidylinositol 3-Kinase/Akt and Mitogen-Activated Protein Kinase (MAPK) Pathways: An Effective Therapeutic Strategy for Endometrial Cancer” [Journal of Cancer Therapy, 6, 1083-1092]
Abstract: The original online version of this article (Guo, R., Wang, X., Zhang, R., Shi, H., Qiao, Y., Yun, W., Ge, X., Lin, Y. and Lei, J. (2015) Response of Subcutaneous Xenografts of Endometrial Cancer in Nude Mice to Inhibitors of Phosphatidylinositol 3-Kinase/Akt and Mitogen-Activated Protein Kinase (MAPK) Pathways: An Effective Therapeutic Strategy for Endometrial Cancer. Journal of Cancer Therapy, 6, 1083-1092. https://doi.org/10.4236/jct.2015.612118) was published in November 2015. The authors wish to correct the following error.
Keywords: Erratum

The original online version of this article (Guo, R., Wang, X., Zhang, R., Shi, H., Qiao, Y., Yun, W., Ge, X., Lin, Y. and Lei, J. (2015) Response of Subcutaneous Xenografts of Endometrial Cancer in Nude Mice to Inhibitors of Phosphatidylinositol 3-Kinase/Akt and Mitogen-Activated Protein Kinase (MAPK) Pathways: An Effective Therapeutic Strategy for Endometrial Cancer. Journal of Cancer Therapy, 6, 1083-1092. https://doi.org/10.4236/jct.2015.612118) was published in November 2015. The authors wish to correct the following error.

The original version of Figure 3 is inappropriate. We replace Figure 3 with the following figure:

Figure 3. H/E staining (×40) of xenograft tumors. Representative H/E-stained sections of Ishikawa (A)-(D) and HEC-1A cell (E)-(H) xenografts in different groups. Compared with the controls, the number of tumor cells decreased and the number of nuclei decreased by varying degrees in groups treated with PD98059, LY294002 or a combination of both.

Cite this paper: Guo, R. , Wang, X. , Zhang, R. , Shi, H. , Qiao, Y. , Yun, W. , Ge, X. , Lin, Y. and Lei, J. (2021) Erratum to “Response of Subcutaneous Xenografts of Endometrial Cancer in Nude Mice to Inhibitors of Phosphatidylinositol 3-Kinase/Akt and Mitogen-Activated Protein Kinase (MAPK) Pathways: An Effective Therapeutic Strategy for Endometrial Cancer” [Journal of Cancer Therapy, 6, 1083-1092]. Journal of Cancer Therapy, 12, 577-578. doi: 10.4236/jct.2021.1210048.
References
 
 
Top